CCR Down Under is barely over and we now turn our focus back to Belfast for CCR26, June 10th to 12th, 2026.

Over the rest of December we'll announce the the major trial results to be presented at Titanic Belfast.

Our sixth trial is VICTORY, a multicentre, double-blind, randomised controlled trial evaluating high-dose intravenous vitamin C in adults with severe, life-threatening burn injury. Patients with deep second- and/or third-degree burns involving at least 20% total body surface area are randomly allocated to receive vitamin C at 200 mg/kg/day for 96 hours or placebo, in addition to standard burn care. Conducted across more than 40 burn centres worldwide, the trial tests the hypothesis that vitamin C can reduce organ dysfunction and accelerate recovery after major burns. The primary outcome is time to discharge alive from hospital, with secondary outcomes including ICU and hospital length of stay, organ support, mortality, quality of life, and healthcare resource use.

Registration for CCR26 opens soon!

Added December 26th